ADAM28 is a serological and histochemical marker for non-small-cell lung cancers

2010 ◽  
Vol 127 (8) ◽  
pp. 1844-1856 ◽  
Author(s):  
Hiroaki Kuroda ◽  
Satsuki Mochizuki ◽  
Masayuki Shimoda ◽  
Miyuki Chijiiwa ◽  
Kazunori Kamiya ◽  
...  
Keyword(s):  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancers ◽  
Histochemical Marker

Evaluation of ADAM28 as a serological and histochemical marker for non-small cell lung cancers.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 10599-10599
Author(s):  
H. Kuroda ◽  
M. Shimoda ◽  
M. Kawamura ◽  
H. Nomori ◽  
Y. Okada
Keyword(s):  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancers ◽  
Histochemical Marker

The tyrosine kinase TEK is differentially expressed in non-small cell lung adenocarcinomas.

2020 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
United States ◽  
Tyrosine Kinase ◽  
Lung Adenocarcinoma ◽  
Microarray Data ◽  
The United States ◽  
Small Cell ◽  
Small Cell Lung ◽  
Significant Differential Expression ◽  
Lung Cancers ◽  
Lung Adenocarcinomas

Non-small cell lung adenocarcinoma (NSCLC) is a leading cause of death in the United States and worldwide (1, 2). We mined published microarray data (3, 4, 5) to discover genes associated with NSCLC. We identified significant differential expression of the tyrosine kinase TEK in tumors from patients with NSCLC. TEK may be of relevance to the initiation, progression or maintenance of non-small cell lung cancers.

Exhaustive Review on Lung Cancers: Novel Technologies

2019 ◽  
Vol 15 (9) ◽  
pp. 873-883
Author(s):  
Sajad Khan ◽  
Shahid Ali ◽  
Muhammad
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Immune Therapy ◽  
Small Cell ◽  
X Rays ◽  
Small Cell Lung ◽  
Microscopic Appearance ◽  
Lung Cancers ◽  
Novel Technologies

Background:Lung cancers or (Bronchogenic-Carcinomas) are the disease in certain parts of the lungs in which irresistible multiplication of abnormal cells leads to the inception of a tumor. Lung cancers consisting of two substantial forms based on the microscopic appearance of tumor cells are: Non-Small-Cell-Lung-Cancer (NSCLC) (80 to 85%) and Small-Cell-Lung-Cancer (SCLC) (15 to 20%).Discussion:Lung cancers are existing luxuriantly across the globe and the most prominent cause of death in advanced countries (USA & UK). There are many causes of lung cancers in which the utmost imperative aspect is the cigarette smoking. During the early stage, there is no perspicuous sign/symptoms but later many symptoms emerge in the infected individual such as insomnia, headache, pain, loss of appetite, fatigue, coughing etc. Lung cancers can be diagnosed in many ways, such as history, physical examination, chest X-rays and biopsy. However, after the diagnosis and confirmation of lung carcinoma, various treatment approaches are existing for curing of cancer in different stages such as surgery, radiation therapy, chemotherapy, and immune therapy. Currently, novel techniques merged that revealed advancements in detection and curing of lung cancer in which mainly includes: microarray analysis, gene expression profiling.Conclusion:Consequently, the purpose of the current analysis is to specify and epitomize the novel literature pertaining to the development of cancerous cells in different parts of the lung, various preeminent approaches of prevention, efficient diagnostic procedure, and treatments along with novel technologies for inhibition of cancerous cell growth in advance stages.

Mutational and Expressional Analysis of DOK2 Gene in Non-small Cell Lung Cancers

2011 ◽  
Vol 10 (1) ◽  
pp. 26
Author(s):  
Nam Jin Yoo ◽  
Min Sung Kim ◽  
Sug Hyung Lee
Keyword(s):  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancers ◽  
Expressional Analysis

scholarly journals Optimization of a modeling platform to predict oncogenes from genome‐scale metabolic networks of non‐small‐cell lung cancers

FEBS Open Bio ◽  
2021 ◽  
Author(s):  
You‐Tyun Wang ◽  
Min‐Ru Lin ◽  
Wei‐Chen Chen ◽  
Wu‐Hsiung Wu ◽  
Feng‐Sheng Wang
Keyword(s):  
Metabolic Networks ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancers ◽  
Genome Scale
Sign in / Sign up

Export Citation Format

Share Document